Author | Design | County | Male% | Setting | Prevalence of frailty | Sample size | Age/years | Frailty Criteria | Effect measures | Outcome assessed |
---|---|---|---|---|---|---|---|---|---|---|
Kundi 2020 [18] | PCS | Turkey | 46.6%) | Hospital | 67.40% | 18,234 | 74.1 (7.4) | HFRS | OR | In-hospital mortality |
Hägg 2020 [12] | PCS | Sweden | 48% | Hospital | 44.10% | 250 | 81.01 (8.56) | CFS | HR | in-hospital mortality |
Aw 2020 [8] | PCS | UK | 54% | Hospital | 70.70% | 677 | 81.1 (8.1) | CFS | HR | In-hospital mortality |
Hewitt 2020 [17] | PCS | UK and Italy | 58% | Hospital | 51.25% | 1564 | 74 (64–83) | CFS | HR | In-hospital mortality |
Shi 2020 [24] | RCS | USA | 44.10% | Nursing home | 71.30% | 139 | 85.0 (9.3) | Frailty index | OR | In-hospital mortality |
Maguire 2020 [13] | RCS | UK | 55.30% | Hospital | 37.70% | 224 | older than 20 years | CFS | OR | 30-day mortality |
Cobos-Siles 2020 [25] | RCS | Spain | 57% | Hospital | 35.15% | 128 | 84 (75, 89) | CFS | OR | In-hospital mortality |
Steinmeyer 2020 [16] | RCS | France | 45.00% | Hospital | 11.00% | 94 | 85.5 ± 7.5 | FNDQ | OR | In-hospital mortality |
Owen 2021 [15] | RCS | UK | 54.00% | Hospital | 53.30% | 206 | 78.8 (8.3) | CFS | OR | In-hospital mortality |
Fiorentino 2020 [11] | RCS | USA | NA | Hospital | 64.10% | 374 | NA | Palliative Performance Scale | OR | In-hospital mortality |
Chinnadurai 2020 [19] | PCS | UK | 61.9% | Hospital | 51.20% | 215 | 74 (60–82) | CFS | OR | In-hospital mortality |
Apea 2021 [22] | PCS | UK | 69.70% | Hospital | 51.90% | 831 | Aged 16 years or over | CFS | HR | 30-day mortality |
Tehrani 2021 [20] | PCS | Sweden | NA | Hospital | 30.0% | 143 | Aged> 65 years | CFS | OR | 60-day mortality |
Bielza 2021 [21] | RCS | Spain | 35.40% | Nursing home | NA | 630 | 87 | CFS | OR | 30-day mortality |
Mendes 2020 [23] | RCS | Switzerland | 43% | Hospital | 78.70% | 235 | 86.3 (6.5) | CFS | HR | In-hospital mortality |